关注
Małgorzata Jarończyk
Małgorzata Jarończyk
National Medicines Institute
在 nil.gov.pl 的电子邮件经过验证
标题
引用次数
引用次数
年份
Molecular dynamics of fentanyl bound to μ-opioid receptor
PFJ Lipiński, M Jarończyk, JC Dobrowolski, J Sadlej
Journal of Molecular Modeling 25, 1-17, 2019
662019
Fentanyl family at the mu-opioid receptor: uniform assessment of binding and computational analysis
PFJ Lipiński, P Kosson, J Matalińska, P Roszkowski, Z Czarnocki, ...
Molecules 24 (4), 740, 2019
542019
Theoretical studies on tautomerism and IR spectra of pyrazole derivatives
M Jarończyk, JC Dobrowolski, AP Mazurek
Journal of Molecular Structure: THEOCHEM 673 (1-3), 17-28, 2004
452004
Novel molecular targets of antidepressants
M Jarończyk, J Walory
Molecules 27 (2), 533, 2022
252022
Synthesis of imperatorin analogs and their evaluation as acetylcholinesterase and butyrylcholinesterase inhibitors
S Granica, AK Kiss, M Jarończyk, JK Maurin, AP Mazurek, Z Czarnocki
Archiv der Pharmazie 346 (11), 775-782, 2013
182013
Molecular docking studies, biological and toxicity evaluation of dihydroisoquinoline derivatives as potential anticancer agents
J Ziemska, A Guśpiel, J Jarosz, A Nasulewicz-Goldeman, J Wietrzyk, ...
Bioorganic & Medicinal Chemistry 24 (21), 5302-5314, 2016
172016
The molecular interactions of buspirone analogues with the serotonin transporter
M Jarończyk, Z Chilmonczyk, AP Mazurek, G Nowak, AW Ravna, ...
Bioorganic & medicinal chemistry 16 (20), 9283-9294, 2008
172008
Novel 4-aryl-pyrido [1, 2-c] pyrimidines with dual SSRI and 5-HT1A activity: Part 2
F Herold, Ł Izbicki, A Chodkowski, M Dawidowski, M Król, J Kleps, J Turło, ...
European journal of medicinal chemistry 44 (11), 4702-4715, 2009
162009
The FMO analysis of the molecular interaction of fentanyl derivatives with the μ-opioid receptor
M Jarończyk, PFJ Lipiński, JC Dobrowolski, J Sadlej
Chemical Papers 71, 1429-1443, 2017
122017
New validated HPLC methodology for the determination of (−)-trans-paroxetine and its enantiomer in pharmaceutical formulations with use of ovomucoid chiral …
M Lisowska-Kuźmicz, M Kantor-Boruta, A Jończyk, M Jarończyk, ...
Analytical and Bioanalytical Chemistry 406, 3697-3702, 2014
112014
On isomers and tautomers of Nitro-1-deazapurine: A DFT study
M Jarończyk, JC Dobrowolski
Journal of Molecular Structure: THEOCHEM 858 (1-3), 77-84, 2008
112008
Affinity of fentanyl and its derivatives for the σ 1-receptor
PFJ Lipiński, E Szűcs, M Jarończyk, P Kosson, S Benyhe, A Misicka, ...
Medchemcomm 10 (7), 1187-1191, 2019
102019
The 1-deazapurine derivatives, tautomerism, substituent effect, and aromaticity: A computational study
M Jarończyk, JC Dobrowolski
Computational and Theoretical Chemistry 974 (1-3), 9-15, 2011
102011
In silico screening for novel leucine aminopeptidase inhibitors with 3, 4-dihydroisoquinoline scaffold
J Ziemska, J Solecka, M Jarończyk
Molecules 25 (7), 1753, 2020
92020
Tautomerism of 1, 3-diphospholes: A DFT study
M Jarończyk, JC Dobrowolski, AP Mazurek
Chemical physics letters 406 (1-3), 173-178, 2005
82005
Conformation of six fentanyls revisited
PFJ Lipiński, M Jarończyk, S Ostrowski, JC Dobrowolski, J Sadlej
Computational and Theoretical Chemistry 1086, 18-24, 2016
62016
Synthesis, in vitro binding studies and docking of long-chain arylpiperazine nitroquipazine analogues, as potential serotonin transporter inhibitors
M Jarończyk, K Wołosewicz, M Gabrielsen, G Nowak, I Kufareva, ...
European journal of medicinal chemistry 49, 200-210, 2012
62012
Structural Insights into σ1 Receptor Interactions with Opioid Ligands by Molecular Dynamics Simulations
M Kurciński, M Jarończyk, PFJ Lipiński, JC Dobrowolski, J Sadlej
Molecules 23 (2), 456, 2018
52018
Oncotoxic Properties of Serotonin Transporter Inhibitors and 5-HT1A Receptor Ligands
J Walory, L Mielczarek, M Jarończyk, M Koronkiewicz, J Kossakowski, ...
International Journal of Molecular Sciences 19 (10), 3260, 2018
42018
QSAR, docking studies and toxicology prediction of isoquinoline derivatives as leucine aminopeptidase inhibitors
J Ziemska, J Solecka, M Jarończyk
Chemical Papers 71, 2557-2568, 2017
42017
系统目前无法执行此操作,请稍后再试。
文章 1–20